New trends in synthetic drugs in the EU: epidemiology and demand-reduction responses

Series type: Insights

Summary

In June 1997, the EMCDDA was assigned a major role by the Council of the EU in the detection and risk assessment of new synthetic drugs. Later that year, it published New trends in synthetic drugs in the European Union, based on two Europe-wide reviews of the epidemiology of synthetic drug use and related demand-reduction activities in the EU. The publication responded to a clear need to audit what was known of the new synthetic drug phenomenon at that time across Europe and to develop a comprehensive knowledge base for informing policy, legislation and prevention initiatives in this area.

Download as PDF

Table of contents

  • The drugs
  • New trends
  • The epidemiology of synthetic drugs
  • Demand reduction and synthetic drugs
Issue: 
1
Pages: 
135
Price: 
EUR
ISBN: 
92-9168-030-3
Catalog Number: 
AO1097219ENC

Order this publication from the EU Bookshop >>